CDY1 Antibody (N-term) Blocking Peptide
Synthetic peptide
- SPECIFICATION
- CITATIONS
- PROTOCOLS
- BACKGROUND
Primary Accession | Q9Y6F8 |
---|---|
Clone Names | 110826072 |
Gene ID | 253175;9085 |
---|---|
Other Names | Testis-specific chromodomain protein Y 1, CDY1, CDY1A |
Format | Peptides are lyophilized in a solid powder format. Peptides can be reconstituted in solution using the appropriate buffer as needed. |
Storage | Maintain refrigerated at 2-8°C for up to 6 months. For long term storage store at -20°C. |
Precautions | This product is for research use only. Not for use in diagnostic or therapeutic procedures. |
Name | CDY1 |
---|---|
Synonyms | CDY1A |
Function | Has histone acetyltransferase activity, with a preference for histone H4. |
Cellular Location | Nucleus. |
Tissue Location | Testis-specific. Detected in spermatids (at protein level). |
Thousands of laboratories across the world have published research that depended on the performance of antibodies from Abcepta to advance their research. Check out links to articles that cite our products in major peer-reviewed journals, organized by research category.
info@abcepta.com, and receive a free "I Love Antibodies" mug.
Provided below are standard protocols that you may find useful for product applications.
Background
This gene encodes a protein containing a chromodomain anda histone acetyltransferase catalytic domain. Chromodomain proteinsare components of heterochromatin-like complexes and can act asgene repressors. This protein is localized to the nucleus of latespermatids where histone hyperacetylation takes place. Histonehyperacetylation is thought to facilitate the transition in whichprotamines replace histones as the major DNA-packaging protein. Thehuman chromosome Y has two identical copies of this gene within apalindromic region; this record represents the more centromericcopy. Chromosome Y also contains a pair of closely related genes inanother more telomeric palindrome as well as several relatedpseudogenes. Two protein isoforms are encoded by transcriptvariants of this gene. Additional transcript variants have beendescribed, but their full-length nature has not been determined.
References
Kleiman, S.E., et al. Hum. Genet. 113(6):486-492(2003)Dorus, S., et al. Hum. Mol. Genet. 12(14):1643-1650(2003)Skaletsky, H., et al. Nature 423(6942):825-837(2003)Lahn, B.T., et al. Proc. Natl. Acad. Sci. U.S.A. 99(13):8707-8712(2002)Ferlin, A., et al. J. Endocrinol. Invest. 24 (2), RC4-RC6 (2001) :
If you have used an Abcepta product and would like to share how it has performed, please click on the "Submit Review" button and provide the requested information. Our staff will examine and post your review and contact you if needed.
If you have any additional inquiries please email technical services at tech@abcepta.com.